Restraining PI3K: mTOR signalling goes back to the membrane

Trends in Biochemical Sciences

Volumn 30, Issue 1, 2005, Pages 35-42

  Harrington, Laura S ^a   Findlay, Greg M ^a   Lamb, Richard F ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN DERIVATIVE; PROTEIN KINASE B; S6 KINASE; SERINE; TARGET OF RAPAMYCIN KINASE; THREONINE; TUBERIN;

BINDING AFFINITY; CELL MEMBRANE TRANSPORT; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HETEROZYGOSITY; INSULIN RESISTANCE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NONHUMAN; NULL ALLELE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MEMBRANE; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN KINASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SOMATOMEDINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 11844304072     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.11.003     Document Type: Review

References (80)

1. R. Katso Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu. Rev. Cell Dev. Biol. 17 2001 615 675
2. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
3. M.F. White Insulin signaling in health and disease Science 302 2003 1710 1711
4. J.A. Fresno Vara PI3K/Akt signalling pathway and cancer Cancer Treat. Rev. 30 2004 193 204
5. W.S. Chen Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene Genes Dev. 15 2001 2203 2208
6. J. Verdu Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB Nat. Cell Biol. 1 1999 500 506
7. B.D. Manning Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway Mol. Cell 10 2002 151 162
8. K. Inoki TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat. Cell Biol. 4 2002 648 657
9. C.J. Potter Akt regulates growth by directly phosphorylating Tsc2 Nat. Cell Biol. 4 2002 658 665
10. M. van Slegtenhorst Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products Hum. Mol. Genet. 7 1998 1053 1057
11. A.R. Tee Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb Curr. Biol. 13 2003 1259 1268
12. A. Garami Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 Mol. Cell 11 2003 1457 1466
13. K. Inoki Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling Genes Dev. 17 2003 1829 1834
14. Y. Zhang Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins Nat. Cell Biol. 5 2003 578 581
15. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev. 18 2004 1926 1945
16. E.J. McManus, and D.R. Alessi TSC1-TSC2: a complex tale of PKB-mediated S6K regulation Nat. Cell Biol. 4 2002 E214 E216
17. P.P. Roux Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase Proc. Natl. Acad. Sci. U. S. A. 101 2004 13489 13494
18. K. Inoki TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590
19. H. Hanafusa Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway Nat. Cell Biol. 4 2002 850 858
20. H.J. Kim, and D. Bar-Sagi Modulation of signalling by Sprouty: a developing story Nat. Rev. Mol. Cell Biol. 5 2004 441 450
21. E. Araki Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene Nature 372 1994 186 190
22. D.J. Withers Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900 904
23. T. Haruta A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 Mol. Endocrinol. 14 2000 783 794
24. R. Zhande Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1 Mol. Cell. Biol. 22 2002 1016 1026
25. C.E. Berg Rapamycin partially prevents insulin resistance induced by chronic insulin treatment Biochem. Biophys. Res. Commun. 293 2002 1021 1027
26. L. Pirola Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells J. Biol. Chem. 278 2003 15641 15651
27. M.W. Greene Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation J. Biol. Chem. 278 2003 8199 8211
28. D. Hartley, and G.M. Cooper Role of mTOR in the degradation of IRS-1: regulation of PP2A activity J. Cell. Biochem. 85 2002 304 314
29. F. Tremblay, and A. Marette Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells J. Biol. Chem. 276 2001 38052 38060
30. 307 J. Biol. Chem. 275 2000 9047 9054
31. K. Paz A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation J. Biol. Chem. 272 1997 29911 29918
32. M.W. Greene, and R.S. Garofalo Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation Biochemistry 41 2002 7082 7091
33. Y. Zick Insulin resistance: a phosphorylation-based uncoupling of insulin signaling Trends Cell Biol. 11 2001 437 441
34. V. Aguirre Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action J. Biol. Chem. 277 2002 1531 1537
35. Y.H. Lee c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade J. Biol. Chem. 278 2003 2896 2902
36. L.V. Ravichandran Protein kinase C-ζ phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin J. Biol. Chem. 276 2001 3543 3549
37. K. Moeschel Protein kinase C-ζ-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1 J. Biol. Chem. 279 2004 25157 25163
38. P. Gual Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes J. Biol. Chem. 278 2003 26550 26557
39. P. Gual MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632 Diabetologia 46 2003 1532 1542
40. C.J. Carlson Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation Biochem. Biophys. Res. Commun. 316 2004 533 539
41. O.N. Ozes A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1 Proc. Natl. Acad. Sci. U. S. A. 98 2001 4640 4645
42. D.H. Kim mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2002 163 175
43. K. Hara Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action Cell 110 2002 177 189
44. D.H. Kim GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol. Cell 11 2003 895 904
45. D. Sarbassov dos Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr. Biol. 14 2004 1296 1302
46. K. Hara Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism J. Biol. Chem. 273 1998 14484 14494
47. M.E. Patti Bidirectional modulation of insulin action by amino acids J. Clin. Invest. 101 1998 1519 1529
48. A. Jaeschke Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent J. Cell Biol. 159 2002 217 224
49. D.J. Kwiatkowski A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells Hum. Mol. Genet. 11 2002 525 534
50. L.S. Harrington The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins J. Cell Biol. 166 2004 213 223
51. O.J. Shah Inappropriate activation of the TSC1-TSC2/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies Curr. Biol. 14 2004 1650 1656
52. H. Zhang Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR J. Clin. Invest. 112 2003 1223 1233
53. T. Radimerski Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling Genes Dev. 16 2002 2627 2632
54. H.L. Kenerson Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors Cancer Res. 62 2002 5645 5650
55. E.D. Werner Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302 J. Biol. Chem. 279 2004 35298 35305
56. J. Giraud Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling J. Biol. Chem. 279 2004 3447 3454
57. M.W. Greene Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cδ Biochem. J. 378 2004 105 116
58. S.H. Um Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity Nature 431 2004 200 205
59. L.H. Storlien Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats Am. J. Physiol. 251 1986 E576 E583
60. M. Pende Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice Nature 408 2000 994 997
61. A.B. Jenkins Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo J. Clin. Invest. 82 1988 293 299
62. J.R. Zierath High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect Diabetes 46 1997 215 223
63. C. Yu Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle J. Biol. Chem. 277 2002 50230 50236
64. M. Monfar Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP Mol. Cell. Biol. 15 1995 326 337
65. A. Khan Serotonin activates S6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes J. Neurosci. 21 2001 382 391
66. N. Takei Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin J. Biol. Chem. 276 2001 42818 42825
67. Y. Kido Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 J. Clin. Invest. 105 2000 199 205
68. N.J. Kerouz Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse J. Clin. Invest. 100 1997 3164 3172
69. E.D. Werner Insulin resistance due to phosphorylation of IRS-1 at serine 302 J. Biol. Chem. 279 2004 35298 35308
70. B. Raught Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases EMBO J. 23 2004 1761 1769
71. H. Flotow, and G. Thomas Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver J. Biol. Chem. 267 1992 3074 3078
72. K.F. Wilson Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex J. Biol. Chem. 275 2000 37307 37310
73. Z. Gao Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex J. Biol. Chem. 277 2002 48115 48121
74. N. Horike Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2 J. Biol. Chem. 278 2003 18440 18447
75. S.N. Jakobsen 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside J. Biol. Chem. 276 2001 46912 46916
76. H. Eldar-Finkelman, and E.G. Krebs Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action Proc. Natl. Acad. Sci. U. S. A. 94 1997 9660 9664
77. Y. Li PKCθ inhibits insulin signaling by phosphorylating IRS1 at Ser1101 J. Biol. Chem. 279 2004 45304 45307
78. K. De Fea, and R.A. Roth Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612 Biochemistry 36 1997 12939 12947
79. K. De Fea, and R.A. Roth Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase J. Biol. Chem. 272 1997 31400 31406
80. Y.F. Liu Insulin stimulates PKCζ-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins J. Biol. Chem. 276 2001 14459 14465